Close Menu

NEW YORK – Bio-Rad Laboratories reported Thursday after the close of the market that its second quarter revenues fell 6 percent year over year, primarily due to COVID-19 pandemic-related slowdowns.

For the three months ended June 30, 2020, Bio-Rad reported revenues of $536.9 million compared to $572.6 million a year ago, besting analysts' average estimate of $517.1 million.

On a currency-neutral basis, Q2 revenues decreased about 4 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.